A new technology for detecting low glucose levels via ECG using a non-invasive wearable sensor, which with the latest Artificial Intelligence can detect hypoglycaemic events from raw ECG signals has been made by researchers from the University of Warwick. Currently Continuous Glucose Monitors (CGM) are available by the NHS for hypoglycaemia detection (sugar levels into...
An Idea From Physics Helps AI See in Higher Dimensions
ARTIFICIAL INTELLIGENCE An Idea From Physics Helps AI See in Higher DimensionsThe laws of physics stay the same no matter one’s perspective. Now this idea is allowing computers to detect features in curved and higher-dimensional space. Computers can now drive cars, beat world champions at board games like chess and Go, and even write prose....
An Out-of-the-Box Attack on Diabetes
Researchers use proteomics to pinpoint new prevention strategy for type 1 diabetes A protein newly identified as important in type 1 diabetes can delay onset of the disease in diabetic mice, providing a new target for prevention and treatment in people, according to research led by scientists at the Department of Energy’s (DOE) Pacific Northwest...
Wearables, Ingestibles, Invisibles: imec at CES 2020
MEDGADGET EDITORSCARDIOLOGY, EXCLUSIVE, GI, MATERIALS, MEDICINE The Belgian research organization imec has a dear spot in our hearts, as it helps to develop a lot of the technologies that power current and future medical devices (see flashbacks below). At CES in Las Vegas this year, imec’s Chris Van Hoof introduced us to the organization’s somewhat...
Synthetic neurons project offers platform for disease treatment, further brain research
A Purdue research project is taking an engineering approach to build synthetic neurons. The body can recover from many things, but the damage caused by Parkinson’s disease isn’t one of them. No cure exists for Parkinson’s, which 1 million people in the U.S. are expected to be living with by 2020. But an outright cure...
New discovery makes it easier to design synthetic proteins that rival their natural counterparts
Researchers, led by UC Berkeley engineers, have created a synthetic material that is as effective as naturally occurring proteins in transporting molecules through membranes, a major milestone that could transform such fields as medicine, life sciences, alternative energy and environmental science. Mimicking transmembrane proteins, which act as gatekeepers in living cells, has been a key...
Insulin made from egg yolk promises cheaper treatment for diabetics
By Nick Lavars The insulin pumps diabetics currently rely on do a great job of delivering the hormone as needed, but need regular replacing due to what are known as fibrils. These form over a day or two as insulin compounds accumulate into clumps and create the risk of blockages, but scientists in Australia have...
AQAMAN takes aim at rare neurodegenerative diseases
by The Chinese University of Hong Kong, Shenzhen A synthetic small molecule compound called AQAMAN can prevent and even reverse harmful protein build-up in neurons that is associated with several rare neurodegenerative disorders, including polyglutamine (or polyQ) diseases. People with polyQ diseases, such as Huntington’s and Machado-Joseph diseases, lose muscle control and coordination as nerve...
Serotonin is a master regulator of neuroregeneration
by John Hewitt , Medical Xpress Neuroregeneration entails not only neurogenesis, but also regrowth of lost connections and birth of non-neuronal cells. While adult neurogenesis in humans is only known to occur definitively in a few precisely circumscribed regions of the brain, work in other species suggests that science has only scratched the surface of...
Wonder drug? Exploring the molecular mechanisms of metformin, a diabetes drug with Medieval roots
by Delthia Ricks , Medical Xpress At only pennies per dose, metformin is a Type 2 diabetes drug with distant roots in Medieval folk medicine and a powerful capacity to reduce body weight, fat mass, circulating glucose—and prevent the disorder altogether in people at elevated risk. New research on the most widely prescribed Type 2...